Stock Movers Closing Bell: CoreWeave Climbs, Pfizer Gains, Spotify Falls on Leadership Change
Sep 30, 2025
CoreWeave skyrockets after securing a monumental $14.2 billion deal with Meta to supply cloud computing power, shifting its dependency from Microsoft. Pfizer celebrates a boost as it plans to sell medications at lower prices through Medicaid, following a report of a new agreement with the Trump administration. Meanwhile, Spotify's stock takes a hit as CEO Daniel Ek steps down, creating uncertainty in leadership. This shift is accompanied by a drop in sports betting stocks amidst emerging competition.
AI Snips
Chapters
Transcript
Episode notes
CoreWeave's Big Meta Win
- CoreWeave signed a long-term deal to supply Meta up to $14.2 billion in compute through 2031 with an option into 2032.
- The agreement diversifies CoreWeave away from heavy reliance on Microsoft and boosted its stock significantly YTD.
Pfizer Gains From Pricing Agreement
- Pfizer shares climbed after reports President Trump announced a deal for lower drug prices for Medicaid.
- The company also received a three-year grace period from the pharma tariff, lifting sector sentiment.
Fries And Foot Traffic Help Lamb Weston
- Lamb Weston beat estimates as restaurant foot traffic improved, especially at chicken chains.
- Carol Massar mentioned she just likes french fries while discussing the stock's move.